Cargando…

Pseudomonas aeruginosa NfsB and nitro-CBI-DEI – a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy

BACKGROUND: The nitro-chloromethylbenzindoline prodrug nitro-CBI-DEI appears a promising candidate for the anti-cancer strategy gene-directed enzyme prodrug therapy, based on its ability to be converted to a highly cytotoxic cell-permeable derivative by the nitroreductase NfsB from Escherichia coli....

Descripción completa

Detalles Bibliográficos
Autores principales:	Green, Laura K, Syddall, Sophie P, Carlin, Kendall M, Bell, Glenn D, Guise, Christopher P, Mowday, Alexandra M, Hay, Michael P, Smaill, Jeffrey B, Patterson, Adam V, Ackerley, David F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695803/ https://www.ncbi.nlm.nih.gov/pubmed/23758947 http://dx.doi.org/10.1186/1476-4598-12-58

Ejemplares similares

Structure and Dynamics of Three Escherichia coli NfsB Nitro-Reductase Mutants Selected for Enhanced Activity with the Cancer Prodrug CB1954
por: Day, Martin A., et al.
Publicado: (2023)

Engineering the Escherichia coli Nitroreductase NfsA to Create a Flexible Enzyme-Prodrug Activation System
por: Sharrock, Abigail V., et al.
Publicado: (2021)

Functional and Structural Characterization of Diverse NfsB Chloramphenicol Reductase Enzymes from Human Pathogens
por: Mullowney, Michael W., et al.
Publicado: (2022)

Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia
por: Guise, Christopher P., et al.
Publicado: (2014)

Bystander or No Bystander for Gene Directed Enzyme Prodrug Therapy
por: Dachs, Gabi U., et al.
Publicado: (2009)

The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy
por: Green, Laura K., et al.
Publicado: (2013)

Interrogation of the Structure–Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications
por: Ashoorzadeh, Amir, et al.
Publicado: (2022)

E. coli nitroreductase NfsA is a reporter gene for non-invasive PET imaging in cancer gene therapy applications
por: Mowday, Alexandra Marie, et al.
Publicado: (2020)

Alterations in chromosomal genes nfsA, nfsB, and ribE are associated with nitrofurantoin resistance in Escherichia coli from the United Kingdom
por: Wan, Yu, et al.
Publicado: (2021)

Backbone assignment of E. coli NfsB and the effects of addition of the cofactor analogue nicotinic acid
por: Hyde, Eva I., et al.
Publicado: (2021)

Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
por: Denny, William A
Publicado: (2003)

Substrate Mediated Enzyme Prodrug Therapy
por: Fejerskov, Betina, et al.
Publicado: (2012)

Enzyme Models—From Catalysis to Prodrugs
por: Breijyeh, Zeinab, et al.
Publicado: (2021)

E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954
por: Vass, S O, et al.
Publicado: (2009)

Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3
por: Abbattista, Maria R., et al.
Publicado: (2021)

Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy
por: El-Sayed, Ashraf S.A., et al.
Publicado: (2022)

Use of nfsB, encoding nitroreductase, as a reporter gene to determine the mutational spectrum of spontaneous mutations in Neisseria gonorrhoeae
por: Stein, Daniel C, et al.
Publicado: (2009)

PDEPT: polymer-directed enzyme prodrug therapy
por: Satchi, R, et al.
Publicado: (2001)

Asymmetric Synthesis of a CBI-Based Cyclic N-Acyl O-Amino Phenol Duocarmycin Prodrug
por: Uematsu, Mika, et al.
Publicado: (2014)

Prodrug converting enzyme gene delivery by L. monocytogenes
por: Stritzker, Jochen, et al.
Publicado: (2008)

Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy
por: Fuhrmann, Gregor, et al.
Publicado: (2018)

Computational Simulations to Guide Enzyme-Mediated Prodrug Activation
por: Markovic, Milica, et al.
Publicado: (2020)

Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506
por: van der Wiel, Alexander M.A., et al.
Publicado: (2021)

Encapsulated Methionine γ-Lyase: Application in Enzyme Prodrug Therapy of Pseudomonas aeruginosa Infection
por: Morozova, Elena, et al.
Publicado: (2020)

A genetically engineered Escherichia coli strain overexpressing the nitroreductase NfsB is capable of producing the herbicide D-DIBOA with 100% molar yield
por: de la Calle, Maria Elena, et al.
Publicado: (2019)

Design, Synthesis and In-Vitro Biological Evaluation of Antofine and Tylophorine Prodrugs as Hypoxia-Targeted Anticancer Agents
por: Omran, Ziad, et al.
Publicado: (2021)

Antibody directed enzymes revive anti-cancer prodrugs concept.
por: Bagshawe, K. D.
Publicado: (1987)

Preparation of Enzyme-Activated Thapsigargin Prodrugs by Solid-Phase Synthesis
por: Zimmermann, Tomas, et al.
Publicado: (2018)

Enzyme-Catalyzed Kinetic Resolution of Chiral Precursors to Antiviral Prodrugs
por: Xiang, Dao Feng, et al.
Publicado: (2019)

The dinitrobenzamide mustard prodrugs, PR-104A and SN27686, for use in a novel MNDEPT cancer prodrug therapy approach
por: Ball, Patrick, et al.
Publicado: (2023)

IS1-related large-scale deletion of chromosomal regions harbouring the oxygen-insensitive nitroreductase gene nfsB causes nitrofurantoin heteroresistance in Escherichia coli
por: Wan, Yu, et al.
Publicado: (2023)

Plasma clearance of an antibody--enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo.
por: Rogers, G. T., et al.
Publicado: (1995)

Use of horseradish peroxidase for gene-directed enzyme prodrug therapy with paracetamol
por: Tupper, J, et al.
Publicado: (2004)

Development of Inhibitor-Directed Enzyme Prodrug Therapy (IDEPT) for Prostate Cancer
por: Martin, Stacy E., et al.
Publicado: (2014)

Targeting assay of a fusion protein applied in enzyme prodrug therapy
por: Wang, Hao, et al.
Publicado: (2017)

Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy
por: Chis, Adriana Aurelia, et al.
Publicado: (2021)

Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials
por: Spiegelberg, Linda, et al.
Publicado: (2019)

Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo
por: Theys, J, et al.
Publicado: (2006)

Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018)

Prodrugs and prodrug-activated systems in gene therapy
por: Sheikh, Semira, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gghvhc8b8rkep19ic7lsns7osq